Fintel reports that on January 27, 2025, D. Boral Capital initiated coverage of Scilex Holding (NasdaqCM:SCLX) with a Buy ...
D. Boral Capital, a premier investment bank focused on high-quality mid-market and growth issuers, today announced it has ...
Fintel reports that on January 21, 2025, D. Boral Capital initiated coverage of Crexendo (NasdaqCM:CXDO) with a Buy ...
Boral Capital upgraded Citius Pharmaceuticals (CTXR) to Buy from Hold with a $9 price target. Citius owns 90% of Citius Oncology (CTOR), which is close to commercializing Lymphir, an immunotherapy ...
After a four-year wait, a case against construction company Boral of interfering with Aboriginal relics at one of its Tasmanian sites has progressed in court. What’s next. Court documents filed ...